
Dzire SP 100mg/325mg/15mg Tablet
Marketer
Riasmo Lifesciences
Salt Composition
Nimesulide (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Overview Dzire SP 100mg/325mg/15mg Tablet
Combiflam Rx 100mg/325mg/15mg tablets offer pain relief by inhibiting the production of substances that trigger pain, inflammation, and fever. This analgesic promotes tissue repair at inflamed sites. Administer Combiflam Rx with food to minimize gastrointestinal discomfort. Dosage is determined by your physician based on your condition and response. Strictly adhere to prescribed dosage and duration. Common side effects include nausea, vomiting, diarrhea, abdominal pain, elevated liver enzymes, and dyspepsia. Report any concerning or worsening side effects to your doctor, who can advise on mitigation strategies. Prior to use, inform your doctor of any history of peptic ulcers, hypertension, or pre-existing cardiovascular, renal, or hepatic conditions. Disclose all other medications you are taking due to potential interactions. Pregnant or lactating individuals must consult their physician before use. Alcohol consumption should be avoided due to the risk of increased somnolence. Important: Government regulations prohibit the use of Combiflam Rx 100mg/325mg/15mg tablets in children under 12 years of age.
Uses of Dzire SP 100mg/325mg/15mg Tablet
Analgesia
Major Benefits of Dzire SP 100mg/325mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dzire SP 100mg/325mg/15mg Tablet should be administered with food.
Common Side effects of Dzire SP 100mg/325mg/15mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Heartburn
How to use Dzire SP 100mg/325mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The Dzire SP 100mg/325mg/15mg Tablet should be administered with a meal.
How Dzire SP 100mg/325mg/15mg Tablet works:
The combined analgesic and anti-inflammatory action of Dzire SP 100mg/325mg/15mg Tablet stems from its three active components: Nimesulide, Paracetamol, and Serratiopeptidase. Nimesulide, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic Paracetamol, both reduce pain and fever by inhibiting the production of pain and fever-inducing neurochemicals. Serratiopeptidase, a proteolytic enzyme, facilitates healing by targeting and degrading abnormal proteins at inflammatory sites.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dzire SP 100mg/325mg/15mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Pregnancy data on the use of Dzire SP 100mg/325mg/15mg Tablet are lacking. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Dzire SP 100mg/325mg/15mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Dzire SP 100mg/325mg/15mg Tablet on driving ability is unknown. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Dzire SP 100mg/325mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. The use of Dzire SP 100mg/325mg/15mg tablets is contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Dzire SP 100mg/325mg/15mg tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Dzire SP 100mg/325mg/15mg Tablet :
Should you forget a Dzire SP 100mg/325mg/15mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dzire SP 100mg/325mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Pain Relievers |
